Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/4824
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBhavsar, Gaurav-
dc.date.accessioned2014-08-19T04:09:23Z-
dc.date.available2014-08-19T04:09:23Z-
dc.date.issued2014-
dc.identifier.urihttp://hdl.handle.net/123456789/4824-
dc.description.abstractSingle RP-HPLC method for assay and in vitro dissolution study of Candesartan cilexetil in tablets was developed and validated. The separation was accomplished on Brava BDS C18 (150 mm X 4.6 mm), 5 , column under isocratic mode. The optimized mobile phase was Buffer: Acetonitrile (50:50v/v) for both assay and in vitro dissolution study. The flow rate optimized was 1.0 ml/min with detection at 254 nm. The method is validated as per ICH Guideline Q2 (R1) for specificity, linearity, accuracy, precision, robustness, system suitability and solution stability. The linear regression analysis data for the calibration plots showed good linear relationship with concentration range of 35-65 μg/ml for assay determination, 0.44-2.64 μg/ml for in virto dissolution. The developed method was simple, specific, accurate and precise. Thus the developed method can also be applicable to the routine analysis of Candesartan Cilexetil in marketed formulations.en_US
dc.publisherInstitute of Pharmacy, Nirma University, A'baden_US
dc.relation.ispartofseriesPDR00303;-
dc.subjectDissertation Reporten_US
dc.subjectPharmaceutical Analysisen_US
dc.subject12MPHen_US
dc.subject12MPH305en_US
dc.subjectPDR00303en_US
dc.titleSingle RP-HPLC Method for Assay And In Vitro Dissolution Study of Candesartan Cilexetil in Tabletsen_US
dc.typeDissertationen_US
Appears in Collections:M.Pharm. Research Reports, Pharmaceutical Analysis

Files in This Item:
File Description SizeFormat 
PDR00303.pdfPDR003032.65 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.